Search results for " pharmacy."

showing 10 items of 356 documents

Nanometric ion pair complexes of tobramycin forming microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis

2019

Abstract Sustained pulmonary delivery of tobramycin from microparticles composed of drug/polymer nanocomplexes offers several advantages against traditional delivery methods. Namely, in patients with cystic fibrosis, microparticle delivery can protect the tobramycin being delivered from strong mucoadhesive interactions, thus avoiding effects on its diffusion toward the infection site. Polymeric ion-pair complexes were obtained starting from two synthetic polyanions, through impregnation of their solid dissociated forms with tobramycin in aqueous solution. The structure of these polymeric systems was characterized, and their activities were examined against various biofilm-forming Pseudomona…

Pseudomonas aeruginosa infectionpseudomonas aeruginosa infectionsBiocompatibilityCystic FibrosisαPharmaceutical Science02 engineering and technologymedicine.disease_cause030226 pharmacology & pharmacyCystic fibrosisCell Line03 medical and health sciences0302 clinical medicineIon-pair complexmedicineTobramycinHumansPseudomonas InfectionsMicroparticleαβ-Poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA)β-Poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA)chemistry.chemical_classificationDrug CarriersAqueous solutionPseudomonas aeruginosaBiofilms; Cystic fibrosis artificial mucus (CF-AM); Ion-pair complex; Pseudomonas aeruginosa infections; Tobramycin; α; β-Poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA)BiofilmBiofilmPolymerBiofilms; cystic fibrosis artificial mucus (CF-AM); Ion-pair complex; pseudomonas aeruginosa infections; Tobramycin; αβ-Poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA)021001 nanoscience & nanotechnologymedicine.diseaseAnti-Bacterial AgentsMucuschemistryBiofilmsPseudomonas aeruginosaBiophysicsTobramycinNanoparticlescystic fibrosis artificial mucus (CF-AM)0210 nano-technologyPeptidesmedicine.drug
researchProduct

Cutaneous Toxicity Induced by Hibiscus Tea in a Patient Treated with Erlotinib

2017

Pulmonary and Respiratory MedicineHerb-drug interactionsbiologybusiness.industryCutaneous toxicityPharmacologyHibiscusbiology.organism_classification030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisMedicineErlotinibbusinessSkin pathologymedicine.drugJournal of Thoracic Oncology
researchProduct

Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate

2021

Complex iron nanoparticle-based drugs are one of the oldest and most frequently administered classes of nanomedicines. In the US, there are seven FDA-approved iron nanoparticle reference drug products, of which one also has an approved generic drug product (i.e., sodium ferric gluconate (SFG)). These products are indicated for the treatment of iron deficiency anemia and are administered intravenously. On the molecular level, iron nanomedicines are colloids composed of an iron oxide core with a carbohydrate coating. This formulation makes nanomedicines more complex than conventional small molecule drugs. As such, these products are often referred to as nonbiological complex drugs (e.g., by t…

Quality ControlDrugChemistry Pharmaceuticalmedia_common.quotation_subjectIron oxidePharmaceutical ScienceEquivalence Trials as Topic02 engineering and technologyFerric Compounds030226 pharmacology & pharmacyGel permeation chromatography03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePharmacokineticsDynamic light scatteringGeneric drugDrug DiscoveryDrugs GenericHumansInductively coupled plasma mass spectrometrymedia_commonAnemia Iron-Deficiency021001 nanoscience & nanotechnologySmall moleculeDynamic Light ScatteringchemistryChromatography GelNanoparticlesMolecular Medicine0210 nano-technologyUltracentrifugationNuclear chemistryMolecular Pharmaceutics
researchProduct

Quality control of gold nanoparticles as pharmaceutical ingredients

2019

Abstract Nanoparticles are being developed for a wide range of medical applications such as, controlled release, drug delivery systems or imagery, theranostics, implants…. For the moment, there is no legal definition of nanoparticles or nanomaterials for therapeutic use. The specific case of gold nanoparticles is not an exception: their current definition as nanoparticle material does not correspond to classic pharmaceutical ingredients as described in Pharmacopoeias. In this study, more than 30 different batches of citrate stabilized gold nanoparticles (AuNP) were synthesized and analyzed thanks to both classical approaches (UV–Vis spectrophotometry, dynamic light scattering coupled or not…

Quality ControlMaterials sciencePharmaceutical ScienceNanoparticleMetal NanoparticlesNanotechnology02 engineering and technologyAcetates030226 pharmacology & pharmacyCitric AcidNanomaterials03 medical and health sciences0302 clinical medicineCapillary electrophoresisDynamic light scatteringDrug Stability[CHIM.ANAL]Chemical Sciences/Analytical chemistrySpectrophotometrymedicinePolyaminesComputingMilieux_MISCELLANEOUSmedicine.diagnostic_testElectrophoresis Capillary[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences021001 nanoscience & nanotechnologyControlled releaseColloidal goldDrug deliveryGold0210 nano-technology
researchProduct

The Concise Guide To Pharmacology 2021/22: G Protein-Coupled Receptors

2021

The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will s…

RMCytoplasmic and NuclearComputer scienceDatabases PharmaceuticalHumans; Ion Channels; Ligands; Receptors Cytoplasmic and Nuclear; Receptors G-Protein-Coupled; Databases Pharmaceutical; PharmacologyReceptors Cytoplasmic and NuclearIN-VITRO CHARACTERIZATIONPharmacologyLigandsIon ChannelsNORSlaw.inventionReceptors G-Protein-CoupledG-Protein-CoupledDatabases03 medical and health sciencesCALCIUM-SENSING RECEPTOR0302 clinical medicineDELTA-OPIOID RECEPTORlawSummary informationReceptorsHumansHISTAMINE H-3 RECEPTORFATTY-ACID RECEPTORMETABOTROPIC GLUTAMATE-RECEPTOR030304 developmental biologyG protein-coupled receptorPharmacologyGONADOTROPIN-RELEASING-HORMONE0303 health sciencesClinical pharmacologyFORMYL PEPTIDE RECEPTORMUSCARINIC ACETYLCHOLINE-RECEPTOR3. Good health317 Pharmacy030220 oncology & carcinogenesisPharmaceuticalNEGATIVE ALLOSTERIC MODULATORCatalytic receptors
researchProduct

The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and co…

2004

Induction of cytochrome P450 3A (CYP3A) by xenobiotics may lead to clinically relevant drug interactions. In contrast with other CYP3A family members, studies on the inducibility of CYP3A5 indicate conflicting results. We report the induction of CYP3A5 mRNA in 13 of 16 hepatocyte preparations exposed to rifampin. Furthermore, induction of CYP3A5 mRNA was observed in intestinal biopsies in three of eight probands following exposure to the antibiotic. The highest absolute levels of CYP3A5 transcripts were found following rifampin treatment in hepatocytes and intestines from carriers of CYP3A5*1 alleles. Elucidation of the mechanism involved in CYP3A5 induction revealed that constitutively act…

Receptors SteroidTime FactorsCYP3ABiopsyAmino Acid MotifsReceptors Cytoplasmic and NuclearPharmacology030226 pharmacology & pharmacyBiochemistryTransactivation0302 clinical medicineCytochrome P-450 Enzyme SystemGenes ReporterCytochrome P-450 CYP3AIntestinal MucosaReceptorPromoter Regions GeneticGenes Dominant0303 health sciencesPregnane X receptorPregnane X Receptor3. Good healthmedicine.anatomical_structureLiverHepatocyteRifampinPlasmidsProtein BindingTranscriptional ActivationHeterozygoteGenotypeBiologyTransfectionXenobiotics03 medical and health sciencesmedicineHumansRNA MessengerMolecular BiologyAllelesConstitutive Androstane Receptor030304 developmental biologyMessenger RNACYP3A4Cell BiologyMolecular biologyProtein Structure TertiaryHepatocytesRNADrug metabolismTranscription FactorsThe Journal of biological chemistry
researchProduct

Influence of PVP/VA copolymer composition on drug–polymer solubility

2015

In this study, the influence of copolymer composition on drug-polymer solubility was investigated. The solubility of the model drug celecoxib (CCX) in various polyvinylpyrrolidone/vinyl acetate (PVP/VA) copolymer compositions (70/30, 60/40, 50/50 and 30/70 w/w) and the pure homopolymers polyvinylpyrrolidone (PVP) and polyvinyl acetate (PVA) was predicted at 25 °C using a thermal analysis method based on the recrystallization of a supersaturated amorphous dispersion (recrystallization method). These solubilities were compared with a prediction based on the solubility of CCX in the liquid monomeric precursors of PVP/VA, N-vinylpyrrolidone (NVP) and vinyl acetate (VA), using the Flory-Huggins …

Recrystallization (geology)PolymersChemistry PharmaceuticalPharmaceutical Science02 engineering and technologyFlory–Huggins solution theory030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug StabilityPolymer chemistrymedicineVinyl acetateCopolymerSolubilityPolyvinyl acetatePolyvinylpyrrolidonePovidone021001 nanoscience & nanotechnologyMonomerSolubilitychemistryCelecoxibThermodynamicsPolyvinylsCrystallization0210 nano-technologyHydrophobic and Hydrophilic Interactionsmedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

High-Generation Amphiphilic Janus-Dendrimers as Stabilizing Agents for Drug Suspensions

2018

Pharmaceutical nanosuspensions are formed when drug crystals are suspended in aqueous media in the presence of stabilizers. This technology offers a convenient way to enhance the dissolution of poorly water-soluble drug compounds. The stabilizers exert their action through electrostatic or steric interactions, however, the molecular requirements of stabilizing agents have not been studied extensively. Here, four structurally related amphiphilic Janus-dendrimers were synthesized and screened to determine the roles of different macromolecular domains on the stabilization of drug crystals. Physical interaction and nanomilling experiments have substantiated that Janus-dendrimers with fourth gen…

Recrystallization (geology)huumeetPolymers and Plastics116 Chemical sciences02 engineering and technology01 natural sciencesdrugsContact angleMaterials ChemistryHUMAN LECTINSSurface plasmon resonanceta116chemistry.chemical_classificationChemistryBIOLOGICAL-MEMBRANES021001 nanoscience & nanotechnologyPROGRAMMABLE GLYCAN LIGANDSINDOMETHACIN317 PharmacyCLICK CHEMISTRYfarmaseuttinen kemia0210 nano-technologyHydrophobic and Hydrophilic InteractionsDendrimersSURFACEBioengineeringPoloxamer010402 general chemistryRSPOORLY SOLUBLE DRUGBiomaterialsHydrophobic effectSurface-Active AgentsSuspensionslääkeyhdisteetDendrimerAmphiphileGLYCODENDRIMERSOMESta216ta215AlkylMODULAR SYNTHESISWaterPoloxamerCombinatorial chemistry0104 chemical scienceslääkkeet1182 Biochemistry cell and molecular biologypharmaceutical nanosuspensionsCOMPLEX ARCHITECTURESBiomacromolecules
researchProduct

Human primary macrophages scavenge AuNPs and eliminate it through exosomes. A natural shuttling for nanomaterials.

2018

Abstract The use of nanomaterials is increasing but the real risk associated with their use in humans has to be defined. In fact, nanomaterials tend to accumulate in organs over a long period of time and are slowly degraded or eliminated by the body. Exosomes are nanovesicles actively shuttle molecules, including chemical products and metals, through the body. Macrophages scavenge the body from both organic and inorganic substances, and they use to release high amounts of exosomes. We hypothesized that macrophages may have a role in eliminating nanomaterials through their exosomes. We treated human primary macrophages with 20 nm gold nanoparticles (AuNPs), analyzing the presence of AuNPs in…

SP-ICP-MSPharmaceutical ScienceMetal Nanoparticles02 engineering and technologyExosomes030226 pharmacology & pharmacyExosomeMass SpectrometryNanomaterials03 medical and health sciences0302 clinical medicineNanoparticleChemical productsLong periodNanotechnologyHumansCells CulturedPrimary (chemistry)ChemistryMacrophagesGeneral Medicine021001 nanoscience & nanotechnologyMicrovesiclesCell biologyExosomeColloidal goldNTAGold0210 nano-technologyBiotechnologyEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Les apothicaires en Sicile à la fin du Moyen Âge

2018

Between the Fifteenth and Sixteenth centuries, detailed regulations were set to control abuses by apothecaries, to watch over pharmacies, preparations and sales of medicines. There are the sign of a sicilian precocity. But apothecaries, in reality, far from the utopian model proposed by the treaties of the time, seem accustomed to cheat on the quantity and quality. This article aims to reconstruct as complete a picture as possible of the apothecary’s career: its training course based on books but also on apprenticeship in the shop, close to the master, and strategies used to establish within the urban infrastructure.

Sicily pharmacy apothecaries regulation training course social strategies.Settore M-STO/01 - Storia Medievale
researchProduct